A bdominal aortic aneurysm (AAA) is an age-related disease that occurs in ≤9% of adults aged of ≥65 years and is responsible for a significant number of deaths in Western countries.
A bdominal aortic aneurysm (AAA) is an age-related disease that occurs in ≤9% of adults aged of ≥65 years and is responsible for a significant number of deaths in Western countries. 1 Although aggressive management of hypertension and hyperlipidemia is recommended in patients with AAA, these strategies have only little effect on the progression of AAA. Surgery is the only treatment for patients with AAA, but this is costly and associated with high morbidity and mortality. 2 Endovascular repair is associated with lower postoperative mortality rates as compared to open surgical repair; however, there are no significant differences in total mortality or AAA-related mortality in the long term, with a higher incidence of reintervention in endovascular repair. 3 When surgical treatment is not possible, AAAs typically progress to rupture with high mortality primarily because no effective nonsurgical treatment is currently available. Thus, a better understanding of the underlying mechanisms involved in AAA formation may help in identifying new therapeutic targets that could suppress AAA progression and reduce the risk of rupture. January 2015 AAA is considered a chronic inflammatory disease characterized by atherosclerotic changes where infiltrating macrophages release matrix metalloproteinases (MMPs) and degrade extracellular matrix components, including collagen and elastin. [4] [5] [6] Inflammation involved in AAA formation can occur even in the absence of microbial infection; therefore, this is regarded as sterile inflammation. An accumulating body of evidence indicates that several types of sterile inflammation triggered by danger signals and tissue damage are mediated by the inflammasome, a large multiple protein complex in the cytosol that also regulates the production of the proinflammatory cytokine interleukin-1β (IL-1β). 7, 8 To date, several types of the inflammasome have been documented. The bestcharacterized inflammasome is the nucleotide-binding oligomerization domain-like receptor (NLR) family pyrin domain containing 3 (NLRP3) inflammasome. The NLRP3 inflammasome contains NLRP3 associated with apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), which recruits caspase-1 and induces its activation. Caspase-1 is known as an IL-1β-converting enzyme; it processes pro-IL-1β into its mature IL-1β form and induces its release, thereby leading to inflammation and tissue damage.
We have recently shown that the inflammasome is a key player in the pathogenesis of cardiovascular disease. [9] [10] [11] [12] Using mice deficient in ASC and caspase-1, we demonstrated that inflammasome activation in cardiac fibroblasts-but not in cardiomyocytes-is crucially involved in the initial inflammatory response after myocardial ischemia-reperfusion injury. 10 The inflammasome is also involved in the pathophysiology of vascular injury, with ASC deficiency reducing the infiltration of inflammatory cells and the expression of inflammatory cytokines, thereby attenuating neointimal formation after vascular injury. 11 Furthermore, the inflammasome has been implicated in vascular inflammation and atherosclerosis development induced by hypercholesterolemia. 12, 13 These findings indicate that the inflammasome may be involved in cardiovascular sterile inflammation. This premise is further supported by reports describing the inflammasome to be a critical mediator of other sterile inflammatory diseases, including gout, pseudogout, asbestosis, silicosis, Alzheimer disease, metabolic syndrome, and type 2 diabetes mellitus. 7, 8, 14, 15 Therefore, we hypothesized that the inflammasome can mediate the initial inflammatory responses in AAA and can eventually promote its formation.
To test this hypothesis, we used the excellent and most commonly used model of human AAA (ie, a murine AAA model produced by chronic subcutaneous infusion of angiotensin II [AII] into Apoe -/-mice). 5, 16 Furthermore, we aimed to identify the molecular basis underlying inflammasome activation in the process of AAA formation. The findings obtained in this study provide new insights into the role of inflammasomes in the pathophysiology of AAA, suggesting that the inflammasome is a novel potential therapeutic target for preventing AAA progression.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Inflammasome Is Involved in AAA Formation
We first investigated inflammatory responses and ASC expression in human AAA tissues. ASC expression and inflammatory cell infiltration, mainly macrophages (CD68), were clearly visible ( Figure 1A) ; furthermore, double-immunofluorescence staining revealed colocalization of ASC with macrophages (CD68), but not with T cells (CD3) and B cells (CD19), in the adventitia ( Figure 1B ; Figure I in the onlineonly Data Supplement), suggesting the role of the inflammasome in the process of AAA formation. To clarify this role further, we infused Apoe
, and Apoe
Casp1
-/-mice with vehicle or AII (1000 ng/kg·per minute) for 28 days because AII-infused Apoe -/-mice are widely used to investigate the pathogenesis of AAA. 5, 16 At the baseline, no differences in the morphology of the aortas were observed among these 4 groups. As expected, systolic blood pressures were increased at 4 weeks after AII infusion in Apoe -/-mice; however, these parameters did not differ between Apoe -/-mice and Apoe
-/-mice (Table I in the online-only Data Supplement). The serum levels of triglycerides, nonesterified fatty acid, and total cholesterol did not differ between these mice. After AII infusion, AAA was formed in ≈70% of the Apoe -/-mice ( Figure 1C  and 1D ). In contrast, only 15% to 20% of the Apoe
-/-mice showed AAA formation. Maximal aortic diameters in these mice were also significantly lesser than those in the Apoe -/-mice ( Figure 1E ). Histological analyses showed that in AII-infused Apoe -/-mice, the aortic wall developed a marked hypertrophy, with the presence of thrombi, small blood vessels, extracellular matrix, and inflammatory and fibroblast-like cells (Figure 2A ; Figure II in the online-only Data Supplement), consistent with previous reports. 17 Immunohistochemical staining confirmed that the AAA lesions in the Apoe -/-mice contained macrophages (Mac-3), fibroblasts (ER-TR7), and vascular smooth muscle cells (α-smooth muscle actin; Figure 2B ; Figure II in the online-only Data Supplement). Similar to human AAA, ASC was found to be expressed in the adventitial macrophages present in the murine AAA lesions in the Apoe -/-mice. In contrast, aortic wall thickness, as well as inflammatory cell infiltration, and fibrosis were substantially decreased in the Apoe Supplement). These findings demonstrate that the inflammasome is involved in AAA formation, with its inhibition preventing the development of AAA.
Inflammasome Is Involved in Vascular Inflammation and Fibrosis
Because the inflammasome regulates inflammatory response via IL-1β secretion, we next investigated whether IL-1β and other related inflammatory factors are involved in AAA formation. At 28 days after AII infusion, plasma IL-1β levels were significantly higher in Apoe -/-mice when compared with those in the control mice, whereas this IL-1β elevation was lower in Apoe
Casp1
-/-mice ( Figure 3A ). Real-time reverse transcriptase-polymerase chain reaction analysis showed that the mRNA levels of IL-1β (Il1b) and other inflammatory cytokines, such as IL-6 (Il6) and CC chemokine ligand 2 (Ccl2), but not tumor necrosis factor-α (Tnf), were elevated in the AAA tissues from Apoe -/-mice, whereas these elevations were decreased in those from Apoe
-/-mice ( Figure 3B ; Figure IV in the online-only Data Supplement). We also observed no significant difference of IL-18 mRNA expression among these mice (data not shown). Furthermore, as expected from the enhanced fibrosis, similar changes were observed in expression levels of MMP-2 (Mmp2), Mmp9, tissue inhibitors of metalloproteinase-1 (Timp1), and collagen type I and II (Col1a1 and Col3a1; Figure 3B ). These findings suggest that the inflammasome mediates inflammatory and fibrotic responses in the process of AAA formation.
Role of the Inflammasome and MitochondriaDerived Reactive Oxygen Species in the Initiation of AAA Formation
To clarify the role of inflammasome in the development of AAA, we assessed plasma IL-1β levels in the earlier timecourse after AII infusion and found that its levels were markedly higher at 7 days after AII infusion than those at 28 days in the Apoe -/-mice ( Figure 4A ); however, this plasma elevation , Apoe
Casp1
-/-mice infused with vehicle or angiotensin II (AII; 1000 ng/kg per minute) for 28 days. D and E, Quantitative analysis of AAA incidence percentage (D) and maximal aortic diameter (E) of AAA in Apoe -/-mice (n=14), Apoe
, and Apoe of IL-1β was completely inhibited in the Apoe
-/-mice. The protein levels of IL-1β were also increased in the suprarenal aortas, which are susceptible to AAA formation in this murine model, in the Apoe -/-mice; these increases were diminished in the Apoe
, and Apoe Figure 4B ). At 7 days after AII infusion, no change was observed in the appearance of the suprarenal aortas between the Apoe -/-mice and Apoe
-/-mice ( Figure 4C and 4D) . Interestingly, however, histological analysis revealed that disrupted elastic lamellae and intramural hemorrhages were clearly visualized in the vascular walls of Apoe -/-mice; these degradations and hemorrhages were prevented in the Apoe
-/-mice ( Figure 4E ; Figure V in the online-only Data Supplement). We further confirmed that the mRNA levels of inflammatory cytokines and fibrosis-related factors were elevated in the AAA tissues from Apoe -/-mice 7 days after AII infusion. The elevation of Il1b, Il6, and Mmp2 were decreased in those from Apoe
-/-mice ( Figure 4F ). To investigate the role of macrophages, vascular smooth muscle cells, and fibroblasts in the initiation of AAA formation, we performed immunohistochemical analysis and found that macrophages were mainly accumulated in the adventitia in the early phase of AAA formation in Apoe -/-mice, and this accumulation was inhibited in Apoe
-/-mice ( Figure 5A ; Figure VIA in the online-only Data Supplement). IL-1β expression was detected in the adventitia. In addition, ASC was highly expressed in the adventitial macrophages ( Figure 5B ; Figure VIB in the online-only Data Supplement), suggesting the role of the inflammasome in adventitial macrophages in the initiation of AAA formation. Recently, the generation of mitochondria-derived reactive oxygen species (mtROS) has been shown to activate the inflammasome. [18] [19] [20] Therefore, we next determined whether mtROS was generated in the Apoe -/-mice using the fluorescent probes for MitoSOX (a mitochondrial superoxide indicator, red fluorescence). The accumulation of mtROS was clearly visualized with MitoSOX fluorescence in the adventitia ( Figure 5C ; Figure  VII in the online-only Data Supplement). We also confirmed mtROS accumulation in the adventitia using dihydroethidium fluorescences, which were colocalized with the mitochondriaspecific dye MitoTracker (green fluorescence; Figure VIIIA 
-/-mice ( Figure 5D ; Figure IX in the online-only Data Supplement). These results demonstrate that the inflammasome and MMPs were activated in the adventitial macrophages during the initiation of AAA formation and that mtROS may mediate inflammasome activation in adventitial macrophages.
Mechanisms of Inflammasome Activation in Response to AII in Macrophages
To investigate the molecular mechanisms by which AII activates the inflammasome in macrophages further, we used murine macrophage J774 cells and bone marrow-derived macrophages (BMDMs) in vitro. We first confirmed the expression of the main AII receptors, AII type 1 and type 2 receptors (AT1R and AT2R), in both macrophage types ( Figure XA in the online-only Data Supplement). Heart samples served as a positive control for AT1R and AT2R. To investigate the inflammasome activation, we primed the cells with a low dose of lipopolysaccharide to ensure the induction of pro-IL-1β, as described in previously published studies. 21, 22 AII (1-100 nmol/L) stimulated a dose-dependent release of IL-1β by J774 cells ( Figure 6A ). Monosodium urate monohydrate (MSU) crystals were used as a positive control for inflammasome activation. Consistent with the data on J774 macrophages, AII-stimulated IL-1β release was also confirmed in BMDMs; this IL-1β release was completely inhibited in BMDMs isolated from Nlrp3
, and Casp1 -/-mice ( Figure 6B ). Furthermore, the selective AT1R antagonist losartan, but not the selective AT2R antagonist PD123319, significantly inhibited AII-induced IL-1β release ( Figure 6C ). These findings demonstrate that AII stimulated inflammasome activation through an AT1R-dependent pathway in macrophages.
Next, we investigated the potential mechanisms of AIIinduced inflammasome activation. Common pathways implicated in inflammasome activation include potassium efflux and ROS production. 7, 8 IL-1β release in response to AII was eliminated at high extracellular potassium concentrations or by the treatment with a potassium channel blocker glimepiride (Figure XB in the online-only Data Supplement). An antioxidant N-acetyl cysteine treatment also decreased AII-induced IL-1β release. However, AII-induced IL-1β release was not affected by the actin polymerization inhibitor cytochalasin D, which has been shown to block MSU-induced inflammasome activation. 22 These results suggest a role for ROS and potassium efflux in AII-induced inflammasome activation.
Because mtROS was clearly increased in the adventitial macrophages in the early phase of AAA formation, we hypothesized that AII activates the inflammasome via mtROS production in macrophages. AII clearly induced mtROS production, as detected by the fluorescence of MitoSOX ( Figure 6D ). The cells were also incubated with MitoTracker 
Casp1
-/-mice infused with vehicle or angiotensin II (AII) for 28 days (n=5-6). B, Total RNA was extracted from suprarenal region of aortas or abdominal aortic aneurysm of Apoe 
-/-mice infused with vehicle or AII for 28 days and analyzed for the mRNA expression of Il1b, Il6, Ccl2, Tnf, Mmp2, Mmp9, Col1a1, Col3a1, and Timp1 using real-time reverse transcriptase-polymerase chain reaction analysis (n=5-6 for each). Data were analyzed by 1-way ANOVA with Dunnett post hoc test. *P<0.05 and **P<0.01.
to confirm the localization of MitoSOX Red to mitochondria. Antimycin A (Ant A), which inhibits mitochondrial complex III, served as a positive control for mtROS production. Time-lapse confocal microscopy of MitoSOX showed that AII induced mtROS production in a time-dependent manner, and this production was completely prevented by treatment with losartan ( Figure 6E and 6F) . Interestingly, treatment with another inflammasome activator-MSUinduced no production of mtROS. The production of mtROS can lead to mitochondrial membrane permeability transition (MPT) or, conversely, can be generated after the MPT as a consequence of mitochondrial dysfunction. We tested the effect of cyclosporin A, which is a potent inhibitor of MPT, 19 and found that cyclosporin A significantly inhibited 
-/-mice were infused with vehicle or angiotensin II (AII) for 7 days. A, Plasma IL-1β levels were assessed (n=5). B, The protein IL-1β levels in the suprarenal aortas were assessed (n=4-6). C and D, The suprarenal aortas in Apoe -/-and Apoe
-/-mice infused with AII for 7 days. Arrowheads indicate the aortas. Quantitative analysis of maximal aortic diameter (n=8-13). E, The suprarenal aortic sections stained with hematoxylin and eosin (HE) and Elastic van Gieson (EVG) in Apoe -/-and Apoe
-/-mice infused with AII for 7 days (n=4). Arrowheads indicate the hemorrhages. F, Total RNA was extracted from the suprarenal aortas and analyzed for the mRNA expression of Il1b, Il6, Ccl2, Tnf, Mmp2, Mmp9, Col1a1, Col3a1, and Timp1 using real-time reverse transcriptase-polymerase chain reaction analysis (n=5-6 for each). Data were analyzed by 1-way ANOVA with Dunnett post hoc test. *P<0.05. Figure 6G ). In addition, treatment with the mitochondrial-targeted antioxidant MitoTEMPO decreased AII-induced IL-1β release ( Figure 6H ). We further determined caspase-1 activity using a fluorescent cell-permeable detection probe that specifically binds to activated caspase-1 and showed that AII-induced caspase-1 activation was inhibited by cyclosporin A and the caspase-1 inhibitor YVAD-FMK ( Figure 6I ). Finally, we observed that MMP activation was induced by AII but not by MSU, and this AII-induced MMP activation was inhibited by losartan and cyclosporin A ( Figure 6J ). Collectively, these results suggest that AII-induced mitochondrial generation of ROS and MPT might induce inflammasome activation and subsequent MMP activation.
IL-1β release by AII but not by MSU treatment (
Discussion
The major findings of this study indicate that the NLRP3 inflammasome is an essential mediator of vascular inflammation and subsequent AAA formation, and that this inflammasome activation is mediated by mtROS in the adventitial macrophages of the vascular wall. Increasing evidence indicates that inflammation is a major contributing factor to the progression of AAA. However, the exact mechanisms underlying inflammation and its involvement in AAA formation remain unknown. The results of the present study clearly demonstrated the direct link between NLRP3 inflammasome activation and AAA progression. Furthermore, our results clarify the molecular events underlying the inflammation involved in AAA formation and suggest that the NLRP3 inflammasome is a potential novel therapeutic target for AAA progression.
The innate immune system has been considered as the first line of defense against foreign pathogens; however, recent evidences suggest that this system also recognizes noninfectious danger signals and regulates the pathogenesis of diseases characterized by sterile inflammation. 7, 8, 14, 15 Indeed, we have previously showed that ASC deficiency reduces inflammatory cell infiltration and the expression of inflammatory cytokines after vascular injury, thereby attenuating subsequent intimal formation.
11 Recent studies have also demonstrated that cholesterol crystals activate the inflammasome in macrophages and promote the development of atherosclerosis. 12, 13, 23 Collectively, these findings allow us to hypothesize that the inflammasome is an initial sensor for sterile inflammation in vascular walls. In the present study, we found that deficiency of the inflammasome components, such as NLRP3, ASC, or caspase-1, prevented vascular inflammation and AAA formation induced by continuous subcutaneous AII infusion. Particularly, in vitro experiments revealed that AII induces NLRP3 inflammasome activation and subsequent IL-1β release in macrophages. Interestingly, some interactions between renin-angiotensin system and 
Casp1
-/-mice infused with vehicle or angiotensin II for 7 days. A, The suprarenal aortic sections were immunohistochemically stained for Mac-3 (macrophages), ER-TR7 (fibroblasts), α-smooth muscle actin (SMA; vascular smooth muscle cells), and interleukin (IL)-1β. B, The sections were analyzed by double-immunofluorescence staining with antibodies against Mac-3 (green) and apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC; red). DAPI (4',6-diamidino-2-phenylindole; blue) indicates nuclear staining. C, The fresh frozen sections were pretreated with or without Tiron (10 mmol/L) for 30 minutes, and then stained with mtROS fluorescence dye mitochondrial superoxide (MitoSOX). Quantitative analysis was performed (n=4). D, The fresh frozen sections were analyzed by in situ zymography with DQ gelatin to detect gelatinolytic activity of matrix metalloproteinases (MMPs). DAPI (blue) indicates nuclear staining. Representative results of ≥3 independent experiments are shown. Data were analyzed by 1-way ANOVA with Dunnett post hoc test. *P<0.05.
hypercholesterolemia have been suggested. For instance, hypercholesterolemia has been shown to enhance AT1R and function. 24 Although the role of this interaction in NLRP3 inflammasome activation remains to be examined, the present study highlights a novel mechanism of AIImediated inflammatory responses.
We noted that ASC is highly expressed in the adventitial macrophages in human and murine AAA tissues and that , and Casp1 -/-mice were treated with AII (100 nmol/L) or MSU. The levels of IL-1β in the supernatants were assessed (n=4). C, LPS-primed macrophages were treated with AII (100 nmol/L) or MSU in the absence or presence of losartan or PD123319. The levels of IL-1β in the supernatants were assessed (n=5). D, J774 macrophages were treated with AII (100 nmol/L) or Ant A (10 μg/mL) for 120 minutes. The levels of mtROS generation were detected with mitochondrial superoxide (MitoSOX; red). The localization of mitochondria was stained with Mitotracker. E and F, Macrophages were treated with AII or MSU in the absence or presence of losartan. The time-course of mitochondria-derived reactive oxygen species (mtROS) generation was detected with MitoSOX using time-lapse confocal microscopy, and quantitative analysis of mtROS at 20 minutes after AII treatment was performed (n=20). G, Cells were treated with AII or MSU in the absence or presence of cyclosporin A. The levels of IL-1β in the supernatants were assessed (n=4). H, Cells were treated with AII in the absence or presence of MitoTEMPO (80 μmol/L). The levels of IL-1β in the supernatants were assessed (n=5). I, Macrophages were treated with AII in the absence or presence of cyclosporin A or YVAD-FMK. Caspase-1 activity was visualized by incubation with a fluorescent cell-permeable probe that binds only to activate caspase-1 (FLICA). Quantitative analysis was performed (n=15). J, Macrophages were treated with AII or MSU in the absence or presence of cyclosporin A or losartan. The cells were analyzed by in vitro zymography with DQ gelatin to detect gelatinolytic activity. Quantitative analysis was performed (n=10). Data were analyzed by 1-way ANOVA with Dunnett post hoc test. *P<0.05; **P<0.01.
AII activates the inflammasome and subsequently induces IL-1β production in macrophages, indicating that adventitial macrophages are involved in the activation of the inflammasome in the process of AAA formation. Supporting this, previous studies have demonstrated that AAA formation is initiated by the accumulation of macrophages in the adventitia. 25, 26 Tieu et al 27 recently demonstrated that the adventitial IL-6/CCL2 amplification loop accelerates macrophage-mediated vascular inflammation, leading to aortic dissection in AII-infused mice. Interestingly, they observed aortic hemorrhages/dissections in 35% (8 of 23) of the experimental mice, with none being observed in vehicleinfused mice. Similar to their findings, we observed aortic hemorrhages in 35% (7 of 20) of AII-infused Apoe -/-mice but no hemorrhages in Apoe -/-Nlrp3 -/-, Apoe -/-Asc -/-, and Apoe -/-Casp1 -/-mice. Although human aortic dissection is commonly seen in the thoracic aorta, our findings show the potential role of NLRP3 inflammasome in the pathophysiology of aortic dissection. Consistent with the report by Tieu et al, 27 we also observed the upregulation of IL-6 and CCL2 in the AAA tissues from Apoe -/-mice but not in those from Apoe
mice, indicating activation of NLRP3 inflammasome as an upstream event for the induction of IL-6 and CCL2. In fact, because IL-1β is a potent inducer of IL-6 and CCL2, 28 it is assumed that the NLRP3 inflammasome is an initiator of macrophage-mediated inflammation in the adventitia. On the contrary, Cassis et al 29 reported that deficiency of AT1a receptor subtype in bone marrow-derived cells could not protect from AII-induced AAA. Their findings are inconsistent with our findings. Although the reason for this discrepancy is unclear, there are several possible explanations. First, the difference between our study and the study of Cassis et al 29 is the AAA models. We used Apoe -/-mice infused with AII, whereas Cassis et al 29 used Ldlr -/-mice fed a fat-enriched diet and infused with AII. Therefore, we speculate that the AAA models used in each study may have influenced the distinct results. Second, although the study of Cassis et al 29 demonstrated the minor role of AT1a receptor on bone marrow-derived cells in AAA formation, the possible role of AT1b is unclear and cannot be ruled out. Additional investigations are required to elucidate the precise mechanisms of AAA formation.
The molecular basis underlying inflammasome activation and its involvement in the process of AAA formation remains entirely unknown. To date, common essential pathways implicated in inflammasome activation include potassium efflux, lysosomal cathepsin leakage in the cytosol, and generation of ROS 7, 8 although the interplay between these processes is poorly understood. However, previous studies indicate that ROS generation in the vascular wall contributes to the pathogenesis of AAA. 30, 31 In particular, Satoh et al 17 recently reported that cyclophilin A secreted by vascular smooth muscle cells in response to ROS leads to the vascular inflammation and subsequent AAA development. In the present study, we found that mtROS generation and potassium efflux contribute to AII-induced inflammasome activation. Previous investigations demonstrated the importance of ROS production by nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) oxidase in AII signaling. 32 In fact, phagosome-associated NADPH oxidase was initially considered to be the primary source of ROS, which then activated the inflammasome. 22 However, subsequent studies using macrophages deficient in components of the NADPH oxidase revealed that NADPH oxidase was not essential to inflammasome activation. 33 Recent studies also showed that inflammasome activation could occur in the monocytes isolated from chronic granulomatous disease patients with mutations in p47 phox and defects in the NADPH system. 34, 35 Consistent with our findings on the role of mtROS in AIIinduced activation of the NLRP3 inflammasome, Zhou et al 18 and Nakahira et al 19 recently showed the mitochondria to be the major source of ROS, which activates the inflammasome. Interestingly, Dai et al 36 reported that administration of cyclosporin A protects AAA expansion in the rat elastase and murine calcium chloride models in vivo. Although molecular link between mitochondrial dysfunction and inflammasome activation remains to be determined, these data suggest the critical role of mitochondria-dependent NLRP3 inflammasome activation in progression of AAA formation.
In summary, this study demonstrates that the NLRP3 inflammasome is a key mediator in AAA formation. We propose the following mechanism of AAA formation: AII stimulates generation of mtROS and MPT via AT1R in adventitial macrophages, leading to NLRP3 inflammasome activation. The inflammatory responses triggered by the release of IL-1β induce vascular inflammation and the production of other inflammatory cytokines/chemokines, which recruit inflammatory cells and enhance the inflammatory responses. Enhanced inflammation induces the activation of MMPs and promotes disrupted elastic lamellae, thereby resulting in the initiation of AAA formation. These findings suggest the essential role of the NLRP3 inflammasome in AAA formation and identify the NLRP3 inflammasome as a novel therapeutic target for preventing AAA progression.
This study demonstrates that the NLR family pyrin domain containing 3 (NLRP3) inflammasome is a key mediator of vascular inflammation and subsequent abdominal aortic aneurysm formation. Deficiency of the NLRP3 inflammasome components, such as NLRP3, apoptosisassociated speck-like protein containing a caspase recruitment domain, and caspase-1, decreased inflammatory cell infiltration and cytokine expression, elastic lamina degradation, and metalloproteinase activation, resulting in prevention of abdominal aortic aneurysm formation in an angiotensin II-infused murine abdominal aortic aneurysm model. This NLRP3 inflammasome is mediated by mitochondrial reactive oxygen species in the accumulated macrophages in the adventitia. Although additional investigations are required to clarify the role of NLRP3 inflammasome in more detail, our findings indicate the NLRP3 inflammasome as a novel therapeutic target for preventing abdominal aortic aneurysm progression.
Significance
